Abstract
Aim of study was to reduce the frequency of inflammatory complications by optimizing therapeutic approaches during the postpartum period.
 150 patients were examined after physiological delivery (main group) and divided into two study groups (I and II). The first group included 100 postpartum patients who took probiotics for 1 month, beginning 3–5 days after delivery. The second group consisted of 50 postpartum patients who were not prescribed probiotics. The control group included 50 patients of reproductive age.
 The probiotic used in the experiment is the drug PROBEEZ® FEMINA. The materials used for the immunological study were washings of cervical mucus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
